Beta Drugs (BETA) Share Price Falls 9.11%: What the Latest Move Means

Beta Drugs Share Price was at Rs 1,676.2, down 9.11% from the previous close, with market capitalisation at Rs 2,168.87 crore as of 13 October 2026 at 12:53:13 PM IST. The move placed Beta Drugs Share Price firmly in focus for healthcare investors tracking intraday price action and Beta Drugs Stock News. Univest data confirms the move itself, though no company-specific trigger has been identified. The fall matters because the stock opened near the previous close, moved to an intraday high of Rs 1,859.4, and then weakened to a low of Rs 1,666.1. The latest Univest figures also show that Beta Drugs Share Price is now being read alongside valuation, earnings quality and sector comparison rather than only the day’s decline.

For readers following Beta Drugs Share Price Today, the key question is not only what changed on the screen, but how the move compares with the company’s fundamentals and the broader pharmaceuticals & drugs set. Univest data places the stock in the Small Cap category, which helps frame the scale of the company without changing the interpretation of the price fall itself. Beta Drugs Share Price therefore draws attention as a price-action event with valuation context, not as a story built on speculation.

Beta Drugs (BETA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,676.2
Previous Close	Rs 1,844.3
Today's Move	-Rs 168.10 (-9.11%)
Open	Rs 1,845
High	Rs 1,859.4
Low	Rs 1,666.1
Market Capitalisation	Rs 2,168.87 crore
Market Cap Category	Small Cap

Beta Drugs Share Price Today shows a clear intraday decline from Rs 1,844.3 at the previous close to Rs 1,676.2, a drop of Rs 168.1 or 9.11%. The stock opened at Rs 1,845 and touched a high of Rs 1,859.4 before slipping to a low of Rs 1,666.1. That range tells investors exactly how far Beta Drugs Share Price moved during the latest session and where it is trading relative to the earlier benchmark. With a market capitalisation of Rs 2,168.87 crore, Beta Drugs is classified as a Small Cap, which is the correct company-size context for this Beta Drugs Share Price move. At this stage, the event is best understood as a sharp price fall in an active intraday range, with Beta Drugs Share Price Today reflecting a clear reset in market pricing. The next step is to place that move inside Beta Drugs Fundamental Analysis.

Beta Drugs (BETA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,168.87 crore
P/E Ratio	49.44x
P/B Ratio	7.82x
ROE	23.95%
ROCE	25.23%
EPS	Rs 37.3
Book Value Per Share	Rs 235.8
Dividend Yield	0%

Beta Drugs (BETA) fundamental metrics show P/E 49.44x, P/B 7.82x, ROE 23.95%, ROCE 25.23%. Read together, these ratios describe the company's position rather than a recommendation.

Beta Drugs has a market capitalisation of Rs 2,168.87 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.44x, P/B at 7.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.95% and ROCE of 25.23%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 37.3, book value per share of Rs 235.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.63x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	49.44x
Benchmark Median P/E	31.63x
Benchmark Average P/E	47.13x
Benchmark P/E Range	3.21x to 676.52x
Company P/B Ratio	7.82x
Benchmark Median P/B	2.86x
Benchmark Average P/B	4.25x
Company ROE	23.95%
Benchmark Median ROE	11.61%
Benchmark Average ROE	10.59%
Company ROCE	25.23%
Benchmark Median ROCE	13.46%
Benchmark Average ROCE	13.35%
Company Market Capitalisation	Rs 2,168.87 crore
Benchmark Median Market Cap	Rs 814.52 crore
Benchmark Average Market Cap	Rs 13,724.94 crore

Beta Drugs (BETA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Beta Drugs (BETA) has a P/E ratio of 49.44x, which is above the benchmark median of 31.63x, a difference of +56.31%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Beta Drugs (BETA) has a ROE of 23.95%, which is above the benchmark median of 11.61%, a difference of +106.29%. Beta Drugs (BETA) has a ROCE of 25.23%, which is above the benchmark median of 13.46%, a difference of +87.44%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,21,539.16	34.89	4.88	14.85	19.11
Divi's Laboratories	DIVISLAB	2,47,576	85.12	14.1	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,77,251.42	81.6	19.83	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,11,231.65	25.18	4.21	19.69	21.39
Laurus Labs	LAURUSLABS	1,09,796.85	102.34	19.84	18.31	18.2

Beta Drugs (BETA) has a P/E ratio of 49.44x compared with the displayed peer median of 81.6x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 23.95% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 25.23% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Beta Drugs (BETA) has a market capitalisation of Rs 2,168.87 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Beta Drugs

• Beta Drugs Share Price fell 9.11% and is trading well below the previous close.
• The intraday range from Rs 1,666.1 to Rs 1,859.4 keeps Beta Drugs Share Price in focus for price action readers.
• Beta Drugs Fundamental Analysis shows ROE of 23.95% and ROCE of 25.23%, both above the industry median.
• Beta Drugs Share Price carries a P/E of 49.44 and P/B of 7.82, both above the same-industry median.
• Beta Drugs Market Cap of Rs 2,168.87 crore places the stock in the Small Cap category within Healthcare.

About Beta Drugs

Beta Drugs operates in the Pharmaceuticals & Drugs industry within Healthcare. The company is tracked through Beta Drugs Share Price, Beta Drugs Stock News and Beta Drugs Stock Analysis because its business sits in a sector where valuation and return ratios often matter as much as headline price moves. As reflected in the current market data, Beta Drugs is a Small Cap company with a market capitalisation of Rs 2,168.87 crore. Its position in the listed pharma universe is best understood through its earnings profile, return ratios and premium valuation rather than through any single intraday move. For readers using Univest, Beta Drugs Share Price can be followed alongside company-level financial ratios and sector comparison. Beta Drugs Share Price today therefore fits into a broader company overview and market update framework.

Track Beta Drugs Share Price on Univest

Use Beta Drugs (BETA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Users can track Beta Drugs Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights in one place. The same view also helps readers follow Beta Drugs Share Price Today alongside Beta Drugs Latest News, valuation context and peer comparison. Univest keeps Beta Drugs Share Price visible in a format that suits quick checks as well as deeper stock analysis.

Frequently Asked Questions

Why is Beta Drugs Share Price falling today?

Ans. Beta Drugs Share Price is down 9.11% at Rs 1,676.2 versus the previous close of Rs 1,844.3. Univest data confirms the move itself, though no company-specific trigger has been identified.

What is Beta Drugs Share Price Today?

Ans. Beta Drugs Share Price Today is Rs 1,676.2, after opening at Rs 1,845, touching a high of Rs 1,859.4 and a low of Rs 1,666.1 during the latest session. The previous close was Rs 1,844.3.

What is Beta Drugs market capitalisation?

Ans. Beta Drugs has a market capitalisation of Rs 2,168.87 crore. Univest classifies the company as a Small Cap, which provides the size context for Beta Drugs Share Price and its latest decline.

How does Beta Drugs compare on valuation?

Ans. Beta Drugs Share Price carries a P/E of 49.44 and a P/B of 7.82. Both are above the same-industry median of 31.63 and 2.86, respectively, indicating a premium valuation within pharmaceuticals.

What do Beta Drugs ROE and ROCE show?

Ans. Beta Drugs reports ROE of 23.95% and ROCE of 25.23%. Both are above the industry median and average, which gives Beta Drugs Share Price a stronger return profile than many peers in Healthcare.

What are Beta Drugs EPS and book value?

Ans. Beta Drugs reports EPS of Rs 37.3 and book value of Rs 235.8. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share in Beta Drugs Share Price.

Does Beta Drugs pay a dividend?

Ans. Beta Drugs has a dividend yield of 0. That means there is no current dividend yield contribution in the Beta Drugs Share Price setup, so investors are looking more at earnings and valuation ratios.

How does Beta Drugs compare with healthcare peers?

Ans. Beta Drugs Share Price sits below peers such as Divi’s Laboratories, Torrent Pharmaceuticals and Laurus Labs on market cap, but its ROCE is stronger than each of those names in the comparison set.

Where can investors follow Beta Drugs Share Price updates?

Ans. Investors can track Beta Drugs Share Price on Univest for live updates, valuation ratios, 52-week levels and company insights. That makes Beta Drugs Share Price useful to monitor alongside sector and peer context.